SCHEMBL2118331

SCHEMBL2118331

Cc1ccc(S(=O)(=O)Nc2cc(C)cc(-c3ccc(C#N)cc3)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 8/20 0.62
DRD2 P14416 1/20 0.54
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
DRD3 P35462 1/20 0.54
HTR6 P50406 1/20 0.54
IDO1 P14902 1/20 0.53
TP53 P04637 2/20 0.52
THRB P10828 1/20 0.52
KDM1A O60341 1/20 0.51
BRD4 O60885 2/20 0.50
BRD1 O95696 1/20 0.50
BRPF1 P55201 1/20 0.50
BRD9 Q9H8M2 1/20 0.50
BRD7 Q9NPI1 1/20 0.50
BRPF3 Q9ULD4 1/20 0.50
ACLY P53396 1/20 0.50
KMT2A Q03164 1/20 0.49
MAPT P10636 1/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117837 0.89 STAT3 (0.60) HSD11B1DRD2HTR2AHTR2CDRD3
SCHEMBL2119549 0.84 MAPT (0.46) HSD11B1TP53KMT2AMAPTPOLB
SCHEMBL6555449 0.84 KDM1A (0.68) TP53THRBKDM1ABRD4BRD1
SCHEMBL2119740 0.83 FFAR4 (0.48) HSD11B1TP53KMT2AMAPTPOLB
SCHEMBL2117287 0.83 KDM1A (0.51) HSD11B1IDO1TP53THRBKDM1A
SCHEMBL2118454 0.81 HSD11B1 (0.51) HSD11B1DRD2HTR2AHTR2CDRD3
SCHEMBL2118647 0.81 PIK3CB (0.50) HSD11B1TP53KMT2AMAPTPOLB
SCHEMBL2118170 0.81 MAPT (0.45) HSD11B1TP53KMT2AMAPTPOLB
SCHEMBL2118637 0.81 TUBB4A (0.51) HSD11B1TP53MAPT
SCHEMBL2119979 0.80 ALDH1A1 (0.47) HSD11B1TP53KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1AN, HIF1A, EGLN2 HSD11B1 3280/4885DRD2 4207/4885HTR2A 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.